VLON
Price:
$0.4
Market Cap:
$0
Vallon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medications for central nervous system disorders with a focus on abuse-deterrent medications. Its lead investigational product candidate is ADAIR, an abuse-deterrent oral formulation of immediate-release dextroamphetamine for the treatment of attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. The company is also developing ADMIR, an abuse deterrent formulation of methylphenidate for the treatment of ADHD. Vallon Pharmaceuticals, Inc. was incorporated in 2018 and is based in Philadelphia, Pennsylvania.[Read more]
Industry
Biotechnology
IPO Date
2021-02-10
Stock Exchange
NASDAQ
Ticker
VLON
According to Vallon Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -4615000.00. This represents a change of -100.36% compared to the average of 1.27B of the last 4 quarters.
The mean historical Enterprise Value of Vallon Pharmaceuticals, Inc. over the last ten years is 29.73M. The current -4615000.00 Enterprise Value has changed -1652.37% with respect to the historical average. Over the past ten years (40 quarters), VLON's Enterprise Value was at its highest in in the December 2023 quarter at 1.99B. The Enterprise Value was at its lowest in in the September 2022 quarter at -1278316.54.
Average
29.73M
Median
39.29M
Minimum
-839470.55
Maximum
51.03M
Discovering the peaks and valleys of Vallon Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 10.05%
Maximum Annual Enterprise Value = 51.03M
Minimum Annual Increase = -369.61%
Minimum Annual Enterprise Value = -839470.55
Year | Enterprise Value | Change |
---|---|---|
2023 | 2.26M | -369.61% |
2022 | -839470.55 | -102.36% |
2021 | 35.58M | -30.28% |
2020 | 51.03M | 7.83% |
2019 | 47.33M | 10.05% |
The current Enterprise Value of Vallon Pharmaceuticals, Inc. (VLON) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
12.34M
5-year avg
27.07M
10-year avg
29.73M
Vallon Pharmaceuticals, Inc.’s Enterprise Value is less than Ikena Oncology, Inc. (23.19M), less than Foghorn Therapeutics Inc. (322.29M), greater than Werewolf Therapeutics, Inc. (-19649832.00), less than Clene Inc. (48.28M), less than Immunome, Inc. (727.77M), greater than Zura Bio Limited (-87016028.00), less than Phio Pharmaceuticals Corp. (3.26M), less than Sonnet BioTherapeutics Holdings, Inc. (99.13K), less than 180 Life Sciences Corp. (4.50M), less than Cardio Diagnostics Holdings, Inc. (33.64M), greater than Palisade Bio, Inc. (-4806381.00), less than Quoin Pharmaceuticals, Ltd. (-1445613.00), less than Revelation Biosciences, Inc. (-4305689.00), less than Virax Biolabs Group Limited (4.90M), less than Unicycive Therapeutics, Inc. (29.92M), greater than ContraFect Corporation (-6024930.00), greater than Allarity Therapeutics, Inc. (-12789509.00), less than CNS Pharmaceuticals, Inc. (1.11M), less than Windtree Therapeutics, Inc. (1.23M), less than Panbela Therapeutics, Inc. (7.90M),
Company | Enterprise Value | Market cap |
---|---|---|
23.19M | $59.99M | |
322.29M | $340.90M | |
-19649832.00 | $66.40M | |
48.28M | $40.05M | |
727.77M | $880.62M | |
-87016028.00 | $101.20M | |
3.26M | $8.65M | |
99.13K | $4.85M | |
4.50M | $4.23M | |
33.64M | $34.90M | |
-4806381.00 | $2.88M | |
-1445613.00 | $1.67M | |
-4305689.00 | $2.24M | |
4.90M | $8.27M | |
29.92M | $61.46M | |
-6024930.00 | $0 | |
-12789509.00 | $4.34M | |
1.11M | $8.05M | |
1.23M | $1.52M | |
7.90M | $1.65M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vallon Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vallon Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Vallon Pharmaceuticals, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Vallon Pharmaceuticals, Inc. (VLON)?
What is the 3-year average Enterprise Value for Vallon Pharmaceuticals, Inc. (VLON)?
What is the 5-year average Enterprise Value for Vallon Pharmaceuticals, Inc. (VLON)?
How does the current Enterprise Value for Vallon Pharmaceuticals, Inc. (VLON) compare to its historical average?